Abstract:Pyrazolines show a variety of biological activities. They are antimicrobial [<a href="#CR1">1</a>, <a href="#CR2">2</a>, <a href="#CR3">3</a>, <a href="#CR4">4</a>], antifungal [<a href="#CR5">5</a>], anti-depressant [<a href="#CR6">6</a>], immunosuppressive [<a href="#CR7">7</a>], anticonvulsant [<a href="#CR8">8</a>, <a href="#CR9">9</a>, <a href="#CR10">10</a>], anti-tumor [<a href="#CR11">11</a>], anti-amoebic [<a href="#CR12">12</a>], antibacterial [<a href="#CR13">13</a>], anti-inflammatory [<a href="#CR14">14</a>], anticancer [<a href="#CR15">15</a>], and MAO inhibitory activity [<a href="#CR16">16</a>]. Hydrazonoyl halides have been widely used as reagents for the synthesis of various heterocyclic compounds [<a href="#CR17">17</a>, <a href="#CR18">18</a>]. Thiazoles are used in drugs developed for the treatment of allergies [<a href="#CR19">19</a>], hypertension [<a href="#CR20">20</a>], inflammation [<a href="#CR21">21</a>], schizophrenia [<a href="#CR22">22</a>], bacterial infections [<a href="#CR23">23</a>], HIV [<a href="#CR24">24</a>], sleep disorders [<a href="#CR25">25</a>] and more recently, for the treatment of pain [<a href="#CR26">26</a>]. They are also used as fibrinogen receptor antagonists with antithrombotic activity [<a href="#CR27">27</a>], and as new inhibitors of bacterial DNA gyrase B [<a href="#CR28">28</a>]. Moreover, 1,3,4-thiadiazoles are among the most common heterocyclic pharmacophores. They display a broad spectrum of biological activities, including antimicrobial [<a href="#CR29">29</a>], anticancer [<a href="#CR30">30</a>, <a href="#CR31">31</a>], antioxidant [<a href="#CR32">32</a>], anti-depressant [<a href="#CR33">33</a>], anticonvulsant [<a href="#CR34">34</a>, <a href="#CR35">35</a>] and antihypertensive activities [<a href="#CR36">36</a>], as well as acetyl cholinesterase inhibition for the treatment of Alzheimer's disease [<a href="#CR37">37</a>, <a href="#CR38">38</a>]. In continuation of the author's research work [<a href="#CR39">39</a>, <a href="#CR40">40</a>, <a href="#CR41">41</a>, <a href="#CR42">42</a>, <a href="#CR43">43</a>, <a href="#CR44">44</a>, <a href="#CR45">45</a>], the synthesis of some new thiazoles, 1,3,4-thiadiazoles and pyrano[2,3-d]thiazole from 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide are reported herein.

Novel Triazole-, Oxadiazole-, and Pyrazole-Nicotinonitrile Hybrids: Synthesis, DFT Study, Molecular Docking, and Antimicrobial Activity

Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine–Pyrazole Hybrid Derivatives

Synthesis, Docking Study, and Antimicrobial Activity of Some New Heterocyclic Compounds Bearing Naphthalene Moiety

Novel thiazole derivatives: Design, synthesis, antibacterial evaluation, DFT, molecular docking and in-silico ADMET investigations

Design, Synthesis, Antimicrobial Activity, and Molecular Docking of Novel Thiazoles, Pyrazoles, 1,3-Thiazepinones, and 1,2,4-Triazolopyrimidines Derived from Quinoline-Pyrido[2,3-d] Pyrimidinones

Synthesis and biological evaluation of new 1,3,4-thiadiazole derivatives as potent antimicrobial agents

Synthesis of tetrazole hybridized with thiazole, thiophene or thiadiazole derivatives, molecular modelling and antimicrobial activity

Synthesis and antibacterial activities of novel hybrid molecules based on benzothiazole, benzimidazole, benzoxazole, and pyrimidine derivatives, each connected to N -arylacetamide and benzoate groups

Exploring The Antimicrobial Potential of Novel 1,2,4-Triazole Conjugates with Pyrazole: Synthesis, Biological Activity and In Silico Docking

Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents

Synthesis of new methylthiourea-thiophene, -thiazole, and -pyrazole conjugates: Molecular modelling and docking studies as antimicrobial agents

Reactivity of (3‐(4‐Fluorophenyl)oxyran‐2‐yl)(naphthalene‐2‐yl)methanone Toward Some Nucleophiles for Preparing Promising Agents with Antimicrobial and Antioxidant Activities

Greener and Highly Efficient Synthesis, In Silico ADMET and Molecular Docking Studies of Potent Antimicrobial Thiophene Clubbed Pyrazole‐1,2,3‐Triazole Hybrids

Pyrazoline Spiro-oxindole tethered 1,2,3-triazole hybrids: Design, synthesis, antimicrobial efficacy and molecular modelling studies

Design, Synthesis, Molecular Docking, and Evaluation Antioxidant and Antimicrobial Activities for Novel 3-Phenylimidazolidin-4-One and 2-Aminothiazol-4-One Derivatives

Utility of 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide in the synthesis of heterocyclic compounds with antimicrobial activity

Synthesis, Spectroscopic Characterization, Antibacterial Activity, Reactivity Parameters, and Molecular Docking Studies of Some Pyridazine Derivatives

Novel biologically active pyridine derivatives: Synthesis, structure characterization, in vitro antimicrobial evaluation and structure-activity relationship

Synthesis of designed new 1,3,4-oxadiazole functionalized pyrano [2,3-f] chromene derivatives and their antimicrobial activities

Synthesis and docking of new 4-(2-((1-phenyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)thiazol-2-amine derivatives as an antimicrobial agent

Targeted potent antimicrobial and antitumor oxygen-heterocyclic-based pyran analogues: synthesis and computational studies